A study conducted at Zainoel Abidin Hospital in Banda Aceh, Indonesia, has shown that IDegAsp therapy is effective for diabetes patients. The research, considered the first real-world evidence study of its kind in the country, involved a group of patients treated with the therapy. The results indicate a significant improvement in blood sugar control among participants.
The study was led by medical professionals at Syiah Kuala University, collaborating with the hospital. It focused on the long-term effects of IDegAsp, a medication used to manage type 2 diabetes. Researchers monitored patients over several months and compared their health outcomes with those of a control group. The findings suggest that IDegAsp helps maintain stable glucose levels more effectively than traditional treatments.
This research comes as diabetes rates continue to rise in Indonesia, particularly in urban areas. The country has seen an increase in lifestyle-related health issues, prompting a need for more effective treatment options. The study’s results may influence future treatment guidelines and provide hope for patients seeking better management of their condition. The findings are expected to be published in a medical journal, offering valuable insights for healthcare professionals in the region.
